Positive impact of a diagnostic stewardship intervention on syndromic panel ordering practices and inappropriate C. difficile treatment
Infection Control & Hospital Epidemiology · 2025
DOI: 10.1017/ice.2024.180 ↗Kurz gefasst
Fachartikel in der Zeitschrift Infection Control & Hospital Epidemiology, 2025. Verfasst von Dan Ilges und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy Services, Mayo Clinic Arizona, Phoenix, AZ, USA. Hauptthemen laut MEDLINE: Clostridioides difficile, Clostridium Infections, Antimicrobial Stewardship. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).
Abstract (Originalsprache)
Objective
Multiplex polymerase chain reaction (PCR) panels for stool testing may be used to diagnose Clostridioides difficile , which can circumvent more appropriate targeted C. difficile testing, resulting in treatment of incidentally detected colonization. We sought to reduce C. difficile diagnosis via a gastrointestinal pathogen panel (GIPP).
Design
Quasi-experimental, pre/post, retrospective cohort study from January 1, 2022, to January 31, 2024.
Setting
Mayo Clinic Arizona—a single academic medical center and associated clinics. Patients: Adult patients receiving C. difficile testing and/or treatment.
Methods
Preferred C. difficile testing consisted of glutamate dehydrogenase and toxin antigen immunoassay, followed by toxin gene testing for discrepant results. The GIPP contained 22 targets during the baseline period with C. difficile removed during the postintervention period. Surveys were provided to provider and nursing groups, separately, to identify C. difficile ordering practices and knowledge gaps.
Results
At baseline, from January 1, 2022, to January 31, 2023, 2,772 GIPPs were completed for 2,307 unique patients (∼7 per day), primarily for outpatients (1,805 of 2,772, 65%). The most common positive target was C. difficile (517 of 1,018, 51%), which resulted in treatment for C. difficile infection in 94.9% (337 of 355) of cases. Following GIPP C. difficile target removal, GIPP orders decreased from 3.23 to 2.7 per 1,000 patient visits ( P < .001). Prescribing of C. difficile treatments decreased in the postintervention period in inpatient and outpatient settings. There were no cases of delayed C. difficile diagnosis during the postintervention period.
Conclusions
Removing C. difficile from the GIPP resulted in effective diagnostic and antimicrobial stewardship without resulting in delayed diagnoses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy Services, Mayo Clinic Arizona, Phoenix, AZ, USA.
- Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Phoenix, AZ, USA.
- Division of Infectious Diseases, Honor Health, Phoenix, AZ, USA.
- Division of Clinical Informatics & Practice Support, Mayo Clinic Arizona, Phoenix, AZ, USA.
- Quality Management Services, Mayo Clinic Arizona, Phoenix, AZ, USA.
- Division of Infectious Diseases, Mayo Clinic Arizona, Phoenix, AZ, USA.
ORCID-Profile: Dan Ilges, Erin H Graf, Leah Grant
Zitieren
APA
Ilges, D., Graf, E. H., Grant, L., Long, A., Siebeneck, E., Seville, M. T., Grys, T., & Speiser, L. J. (2025). Positive impact of a diagnostic stewardship intervention on syndromic panel ordering practices and inappropriate C. difficile treatment. Infection Control & Hospital Epidemiology. https://doi.org/10.1017/ice.2024.180
Vancouver
Ilges D, Graf EH, Grant L, Long A, Siebeneck E, Seville MT, et al. Positive impact of a diagnostic stewardship intervention on syndromic panel ordering practices and inappropriate C. difficile treatment. Infection Control & Hospital Epidemiology. 2025. doi:10.1017/ice.2024.180
BibTeX
@article{Ilges2025,
author = {Ilges, Dan and Graf, Erin H and Grant, Leah and Long, Ashley and Siebeneck, Eric and Seville, Maria Teresa and Grys, Thomas and Speiser, Lisa J},
title = {Positive impact of a diagnostic stewardship intervention on syndromic panel ordering practices and inappropriate C. difficile treatment},
journal = {Infection Control & Hospital Epidemiology},
year = {2025},
doi = {10.1017/ice.2024.180}
}
EUVIMED